The University of Michigan Board of Regents appointed Marschall S. Runge Executive Vice President for Medical Affairs and CEO of Michigan Medicine effective March 2015 and Dean of the Medical School effective January 2016. Before coming to Michigan, Dr. Runge was executive dean for the University of North Carolina (UNC) School of Medicine, the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine at UNC-Chapel Hill (UNC-CH), chair of the UNC-CH Department of Medicine, and principal investigator and director of the NIH-funded North Carolina Translational and Clinical Sciences (NC TraCS) Institute, one of 55 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country.
An honors graduate of Vanderbilt University with a B.A. in Biology and a Ph.D. in Molecular Biology, Dr. Runge earned his M.D. from the Johns Hopkins School of Medicine, where he was an intern and resident in internal medicine. He then completed a cardiology fellowship at Harvard’s Massachusetts General Hospital and was a faculty member at Harvard prior to subsequent career moves. Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in healthcare.